This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Francisco, G. Articles by Simó, R. Search for Related Content PubMed PubMed Citation Articles by Francisco, G. Articles by Simó, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Hypoglycemia

Usefulness of Homeostasis Model Assessment for Identifying Subjects at Risk for Hypoglycemia Failure during the Insulin Hypoglycemia Test

Endocrinology Division (G.F., C.H., R.S.) and Biochemistry Department (R.G.), Hospital Univesitari Vall d’Hebron, 08035 Barcelona, Spain

Address all correspondence and requests for reprints to: Rafael Simó, M.D., Endocrinology Division, Hospital Universitari Vall d’Hebron, Pg. Vall d’Hebron 119-129, 08035 Barcelona, Spain. E-mail: rsimo{at}hg.vhebron.es.

One of the main problems of the insulin hypoglycemia test (IHT) is the failure to achieve an adequate hypoglycemia (blood glucose, <45 mg/dl) with the standard dose of insulin used. The aim of the study was to identify by means of homeostasis model assessment (HOMA) the subjects at risk for hypoglycemia failure during IHT. For this purpose 32 patients in whom an IHT was performed were prospectively included. Receiver operating characteristics curve analyses were performed to assess the sensitivity and specificity of both insulinemia and HOMA. Eight patients (25%) did not reach adequate hypoglycemia. A serum insulin concentration above 17.7 µIU/ml or a HOMA value above 4.38 identified those subjects who would not reach adequate hypoglycemia with a probability of 75%. By contrast, when the levels of either insulinemia or HOMA were lower than the cut-off points mentioned above, the probability that individuals would reach sufficient hypoglycemia was 89.5%. In conclusion, quantitative estimate of insulin resistance by HOMA is a simple and reliable method that permits identification of individuals at risk of not reaching adequate hypoglycemia during IHT. In these patients, either alternative tests or a higher dose of insulin should be considered.

This work was supported by grants from Instituto Carlos III (G03/212, C03/08) and Novo Nordisk Pharma S.A. (01/0066).

Abbreviations: HOMA, Homeostasis model assessment; HPA, hypothalamic-pituitary-adrenocortical; IHT, insulin hypoglycemia test; ROC, receiver operating characteristics curve.

This article has been cited by other articles:

				C. Guo, V. Ricchiuti, B. Q. Lian, T. M. Yao, P. Coutinho, J. R. Romero, J. Li, G. H. Williams, and G. K. Adler Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-{gamma}, and Proinflammatory Adipokines Circulation, April 29, 2008; 117(17): 2253 - 2261. [Abstract] [Full Text] [PDF]